| 000 | 01873 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516051402.0 | ||
| 264 | 0 | _c20121129 | |
| 008 | 201211s 0 0 eng d | ||
| 022 | _a1558-1497 | ||
| 024 | 7 |
_a10.1016/j.neurobiolaging.2011.06.019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGardoni, Fabrizio | |
| 245 | 0 | 0 |
_aTargeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias. _h[electronic resource] |
| 260 |
_bNeurobiology of aging _cSep 2012 |
||
| 300 |
_a2138-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenergic Agents _xtoxicity |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xadverse effects |
| 650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinase Type 2 _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDisks Large Homolog 4 Protein |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xdrug therapy |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xmetabolism |
| 650 | 0 | 4 |
_aLevodopa _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMedial Forebrain Bundle _xdrug effects |
| 650 | 0 | 4 |
_aMembrane Proteins _xmetabolism |
| 650 | 0 | 4 |
_aOxidopamine _xtoxicity |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xmetabolism |
| 650 | 0 | 4 | _aSubcellular Fractions |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aSgobio, Carmelo | |
| 700 | 1 | _aPendolino, Valentina | |
| 700 | 1 | _aCalabresi, Paolo | |
| 700 | 1 | _aDi Luca, Monica | |
| 700 | 1 | _aPicconi, Barbara | |
| 773 | 0 |
_tNeurobiology of aging _gvol. 33 _gno. 9 _gp. 2138-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neurobiolaging.2011.06.019 _zAvailable from publisher's website |
| 999 |
_c21066214 _d21066214 |
||